News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
393,941 Results
Type
Article (26335)
Company Profile (60)
Press Release (367544)
Multimedia
Podcasts (34)
Webinars (7)
Section
Business (104371)
Career Advice (455)
Deals (16887)
Drug Delivery (53)
Drug Development (47731)
Employer Resources (47)
FDA (12348)
Job Trends (8484)
News (186334)
Policy (19523)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1757)
Accelerated approval (14)
Adcomms (10)
Allergies (114)
Alliances (26824)
ALS (97)
Alzheimer's disease (978)
Antibody-drug conjugate (ADC) (162)
Approvals (12683)
Artificial intelligence (308)
Autoimmune disease (93)
Automation (8)
Bankruptcy (142)
Best Places to Work (6891)
BIOSECURE Act (5)
Biosimilars (73)
Biotechnology (40)
Bladder cancer (124)
Brain cancer (37)
Breast cancer (416)
Cancer (3078)
Cardiovascular disease (266)
Career advice (416)
Career pathing (15)
CAR-T (134)
CDC (26)
Celiac Disease (2)
Cell therapy (366)
Cervical cancer (26)
Clinical research (42959)
Collaboration (864)
Compensation (275)
Complete response letters (16)
COVID-19 (1554)
CRISPR (35)
C-suite (497)
Cystic fibrosis (59)
Data (4252)
Decentralized trials (2)
Denatured (20)
Depression (93)
Diabetes (318)
Diagnostics (3719)
Digital health (30)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (95)
Drug pricing (91)
Drug shortages (22)
Duchenne muscular dystrophy (125)
Earnings (38633)
Editorial (29)
Employer branding (6)
Employer resources (47)
Events (54207)
Executive appointments (590)
FDA (14642)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (6)
Frontotemporal dementia (10)
Funding (758)
Gene editing (75)
Generative AI (21)
Gene therapy (261)
GLP-1 (543)
Government (3143)
Grass and pollen (4)
Guidances (229)
Healthcare (12212)
HIV (39)
Huntington's disease (20)
IgA nephropathy (50)
Immunology and inflammation (83)
Immuno-oncology (27)
Indications (72)
Infectious disease (1689)
Inflammatory bowel disease (110)
Inflation Reduction Act (7)
Influenza (54)
Intellectual property (119)
Interviews (40)
IPO (7072)
IRA (23)
Job creations (1846)
Job search strategy (381)
JPM (19)
Kidney cancer (10)
Labor market (35)
Layoffs (195)
Leadership (8)
Legal (3646)
Liver cancer (66)
Longevity (7)
Lung cancer (486)
Lymphoma (252)
Machine learning (16)
Management (17)
Manufacturing (291)
MASH (107)
Medical device (13304)
Medtech (13350)
Mergers & acquisitions (10327)
Metabolic disorders (759)
Multiple sclerosis (100)
NASH (11)
Neurodegenerative disease (163)
Neuropsychiatric disorders (42)
Neuroscience (1701)
NextGen: Class of 2026 (3933)
Non-profit (2837)
Now hiring (35)
Obesity (314)
Opinion (96)
Ovarian cancer (120)
Pain (141)
Pancreatic cancer (140)
Parkinson's disease (164)
Partnered (17)
Patents (225)
Patient recruitment (355)
Peanut (43)
People (35663)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12343)
Phase 2 (18584)
Phase 3 (15266)
Pipeline (3110)
Policy (126)
Postmarket research (1668)
Preclinical (3800)
Press Release (18)
Prostate cancer (179)
Psychedelics (26)
Radiopharmaceuticals (178)
Rare diseases (433)
Real estate (2869)
Recruiting (19)
Regulatory (15710)
Reports (18)
Research institute (1655)
Resumes & cover letters (49)
Rett syndrome (16)
RNA editing (5)
RSV (39)
Schizophrenia (113)
Series A (116)
Series B (94)
Service/supplier (2)
Sickle cell disease (45)
Special edition (6)
Spinal muscular atrophy (104)
Sponsored (16)
Startups (2134)
Stomach cancer (11)
Supply chain (60)
Tariffs (25)
The Weekly (14)
Vaccines (507)
Venture capital (28)
Weight loss (211)
Women's health (56)
Worklife (4)
Date
Today (71)
Last 7 days (340)
Last 30 days (1103)
Last 365 days (16202)
2026 (1667)
2025 (16467)
2024 (19845)
2023 (22735)
2022 (30680)
2021 (32984)
2020 (32190)
2019 (28412)
2018 (21810)
2017 (18905)
2016 (18111)
2015 (21194)
2014 (16023)
2013 (13242)
2012 (14349)
2011 (14622)
2010 (13182)
Location
Africa (367)
Alabama (30)
Alaska (2)
Arizona (176)
Arkansas (10)
Asia (25502)
Australia (4029)
California (5592)
Canada (1915)
China (792)
Colorado (287)
Connecticut (286)
Delaware (249)
Europe (49914)
Florida (951)
Georgia (225)
Hawaii (1)
Idaho (35)
Illinois (580)
India (32)
Indiana (380)
Iowa (11)
Japan (320)
Kansas (90)
Kentucky (19)
Louisiana (18)
Maine (28)
Maryland (895)
Massachusetts (3761)
Michigan (151)
Minnesota (443)
Mississippi (5)
Missouri (80)
Montana (19)
Nebraska (21)
Nevada (65)
New Hampshire (73)
New Jersey (1935)
New Mexico (10)
New York (1575)
North Carolina (820)
North Dakota (4)
Northern California (2656)
Ohio (214)
Oklahoma (8)
Oregon (28)
Pennsylvania (1359)
Puerto Rico (12)
Rhode Island (35)
South America (523)
South Carolina (59)
Southern California (2246)
Tennessee (126)
Texas (1025)
United States (21724)
Utah (194)
Virginia (142)
Washington D.C. (52)
Washington State (386)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
393,941 Results for "sirtex medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sirtex Receives Expanded CE Mark Approval for SIR-Spheres® Y-90 Resin Microspheres
September 9, 2025
·
2 min read
Press Releases
Sirtex Medical’s SIR-Spheres® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma
July 8, 2025
·
3 min read
Business
Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member
Sirtex Medical announced today the appointment of Matt Schmidt as chief executive officer and board of directors member, effective March 25.
March 25, 2024
·
2 min read
Genetown
Sirtex Medical Announces Commercial Availability of New LAVA® Liquid Embolic System
Sirtex Medical (“Sirtex”), a leading manufacturer of interventional treatment solutions, announced today the commercial availability of the LAVA® Liquid Embolic System, the first and only liquid embolic approved for the treatment of peripheral vascular hemorrhage.
October 27, 2023
·
2 min read
Business
Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept® S DSM 50 μm
Sirtex Medical (“Sirtex”) announced today the establishment of a collaboration and exclusive worldwide distribution agreement with Magle Group, a Sweden-based contract development and manufacturing organization as well as Degradable Starch Microspheres (DSM) sales and marketing company.
September 8, 2023
·
2 min read
Press Releases
Sirtex Medical Announces Certification of SIR-Spheres® Y-90 Resin Microspheres According to Medical Device Regulation (EU) 2017/745 and European Launch of the Innovative SIROS™ Delivery System
September 17, 2024
·
2 min read
Press Releases
Sirtex Medical Launches SIR-Spheres® FLEXdose SELECT Delivery Program to Enable More Selective Y-90 Treatment Plans
August 5, 2024
·
2 min read
Genetown
Sirtex Medical secures positive approval of SIR-Spheres® Y-90 resin microspheres for HCC treatment in Brazil
Sirtex Medical (“Sirtex”), a leading manufacturer of targeted liver cancer therapies, announced that the Brazilian National Agency of Supplementary Health (ANS) approved SIR-Spheres® Y-90 resin microspheres for the treatment of intermediate and advanced stage hepatocellular carcinoma (HCC) in Brazil.
September 15, 2022
·
3 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
·
2 min read
Business
Sirtex Medical announces collaboration update with OncoSec Medical
Sirtex Medical US Holdings, Inc. (“Sirtex”), a leading manufacturer of targeted cancer therapies, announced an advancement in its strategic collaboration with OncoSec Medical, Inc. (NASDAQ: ONCS) relating to OncoSec’s lead product candidate TAVO™ (tavokinogene telseplasmid) and its electroporation (EP) gene delivery system.
January 19, 2021
·
2 min read
1 of 39,395
Next
